Oberland Capital
Oberland Capital is a dedicated healthcare investment firm founded in 2013 and headquartered in New York, with approximately $3.2 billion in assets under management. The firm provides innovative financing solutions — including royalty monetizations, revenue interest financing, and credit facilities — to biopharmaceutical, diagnostic, and medical device companies. Oberland focuses exclusively on the global healthcare industry, targeting commercial-stage and near-commercial-stage companies.
New York, United States · 5+ investments · 4 portfolio companies
- Headquarters
- New York, United States
- Founded
- 2013
- Website
- oberlandcapital.com
- AUM
- $3.2B
- Portfolio Companies
- 4
- Total Investments
- 5
- Last Investment
- Dec 2025
- Geographic Focus
- Global
Investment Thesis
Oberland Capital is a Venture Capital firm based in New York, United States. It has made 5 investments, including Humacyte, ImmunityBio and Biohaven Ltd. Common Shares. Focus areas include Biotech and Healthcare.
Portfolio4
Co-investors24
Sign up to view co-investors
24 co-investors across 24 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×13 · Private Equity ×3 · Growth Equity ×2
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/oberland-capital"><img src="https://indexed.vc/api/badge/investor/oberland-capital" alt="Oberland Capital on Indexed.vc" width="260" height="76" /></a>

